title: New Imaging Technology May Help Doctors Diagnose Amyloidosis: Due to stringent FDA rules, U.S. imaging of the disease has lagged behind Europe but a new synthetic molecule may change that.
abstract: One December day in 2013, Michael Rasmussen realized that just chewing his food made him tired. Short walks felt draining. At one point, he became so tired that he sat down and didn't get up for three days. Rasmussen had been a man in perfect health. For 30 years, he lived as an artist in the Aleutian Islands in Alaska and walked or biked everywhere. He even bicycled across the United States five times. But now he had slid into a horrible medical mystery.
authors.forename: Summer
authors.initials: S
authors.lastname: Allen
mesh_terms: D000686:Amyloidosis / Q000175:diagnosis*; D000818:Animals; D005060:Europe; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D051379:Mice; D057054:Molecular Imaging / Q000379:methods*; D000683:Serum Amyloid P-Component / Q000737:chemistry / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D051598:Whole Body Imaging / Q000379:methods*
chemical_list: D007457:Iodine Radioisotopes; D000683:Serum Amyloid P-Component